Oncopeptides AB (publ) (ONPPF) Stock Price & Growth Analysis

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y 0.00 %

Key Metrics

Market Cap
55.99M
Shares Outstanding
211.26M
Share in Float
183.31M
Dividende
0

Earning Date
05 Nov 2025
Price Target
0.265
Average Volume
8
Beta
-0.547

Range
0.265-0.265
Industry
Biotechnology
Website
https://www.oncopeptides.com/sv
Sector
Healthcare

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

21.54x

P/S Ratio

N/Ax

P/B Ratio

N/A

Debt/Equity

-525.2%

Net Margin

$-0.2

EPS

How ONPPF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

ONPPF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

ONPPF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$221M

129%

2026-Revenue

$0.22

55%

2026-EPS

$133M

-129%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.10
vs -5.23

Q1.23

N/A

-0.08
vs -1.31

Q2.23

N/A

-0.06
vs -0.79

Q3.23

N/A

-0.04
vs -1.00

Q4.23

N/A

-0.09
vs -0.10

Q1.24

N/A

-0.05
vs -0.08

Q2.24

N/A

-0.05
vs -0.06

Q3.24

N/A

-0.04
vs -0.04

Q4.24

N/A

-0.04
vs -0.09

Q1.25

N/A

-0.28
vs -0.05

Sales Growth

YoY

Current

Estimates

Q2.23

+197%

26M vs 8.8M

Q3.23

+393%

2.8M vs -958000

Q4.23

+853%

5.3M vs 560K

Q1.24

+351%

5.1M vs 1.1M

Q2.24

-69%

8.2M vs 26M

Q3.24

+203%

8.5M vs 2.8M

Q4.24

+86%

9.9M vs 5.3M

Q1.25

+162%

13.3M vs 5.1M

Q2.25

+202%

24.7M vs 8.2M

Q3.25

+264%

30.9M vs 8.5M

Return on Equity

QoQ

Q1.23

-31%

-0.31
vs -0.31

Q2.23

-32%

-0.32
vs -0.31

Q3.23

-30%

-0.30
vs -0.32

Q4.23

-143%

-1.43
vs -0.30

Q1.24

+803%

8.03
vs -1.43

Q2.24

-38%

-0.38
vs 8.03

Q3.24

-44%

-0.44
vs -0.38

Q4.24

-154%

-1.54
vs -0.44

Q1.25

+1038%

10.38
vs -1.54

Q2.25

+94%

0.94
vs 10.38

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q4.22

N/A

-0.10
vs -5.23

Q1.23

N/A

-0.08
vs -1.31

Q2.23

N/A

-0.06
vs -0.79

Q3.23

N/A

-0.04
vs -1.00

Q4.23

N/A

-0.09
vs -0.10

Q1.24

N/A

-0.05
vs -0.08

Q2.24

N/A

-0.05
vs -0.06

Q3.24

N/A

-0.04
vs -0.04

Q4.24

N/A

-0.04
vs -0.09

Q1.25

N/A

-0.28
vs -0.05

Sales Growth

YoY

Current

Estimates

Q2.23

+197%

26M vs 8.8M

Q3.23

+393%

2.8M vs -958000

Q4.23

+853%

5.3M vs 560K

Q1.24

+351%

5.1M vs 1.1M

Q2.24

-69%

8.2M vs 26M

Q3.24

+203%

8.5M vs 2.8M

Q4.24

+86%

9.9M vs 5.3M

Q1.25

+162%

13.3M vs 5.1M

Q2.25

+202%

24.7M vs 8.2M

Q3.25

+264%

30.9M vs 8.5M

Return on Equity

QoQ

Q1.23

-31%

-0.31
vs -0.31

Q2.23

-32%

-0.32
vs -0.31

Q3.23

-30%

-0.30
vs -0.32

Q4.23

-143%

-1.43
vs -0.30

Q1.24

+803%

8.03
vs -1.43

Q2.24

-38%

-0.38
vs 8.03

Q3.24

-44%

-0.44
vs -0.38

Q4.24

-154%

-1.54
vs -0.44

Q1.25

+1038%

10.38
vs -1.54

Q2.25

+94%

0.94
vs 10.38

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.27USD

N/A

21.54x

N/Ax

N/A

-525.2%

$-0.2

$221M

$0.22

$133M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

Company Description

0.27USD

$221M

$0.22

$133M

N/A

21.54x

N/Ax

N/A

-525.2%

$-0.2